Short Profile

Gerresheimer is a

leading global partner

… to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and our 11,000 employees manufac-ture our products in local markets, close to our customers. With over 40 plants in Europe, North America, South America and Asia, we generate revenues of approximately EUR 1.4 billion. Our com-prehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insu-lin pens, inhalers, prefillable syringes, injection vials, ampoules, bot-tles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Management Board

Overview

Uwe RöhrhoffChief Executive Officer

Primary Packaging Glass Division

Rainer BeaujeanChief Financial Officer

Life Science ResearchDivision

Andreas Schütte

Plastics & DevicesDivision

The product portfolio of the Plastics & Devices Division includes complex, cus-tomer-specific products for the simple and safe administration of medicines, such as insulin pens, inhalers and prefillable sy-ringes. Also included are diagnostics and medical technology products such as lan-cets and test systems, as well as pharma-ceutical plastic containers for liquid and solid medicines with closure and safety systems. For the North American prescrip-tion retail market a complete line of reg-ulatory compliant prescription containers for medication dispensing is available.

The Primary Packaging Glass Division pro-duces glass primary packaging for med-icines and cosmetics, such as pharma jars, ampoules, injection vials, cartridges, per-fume flacons and cream jars.

The Life Science Research Division produ-ces reusable laboratory glassware for re-search, development and analytics, such as beakers, Erlenmeyer flasks and measu-ring cylinders as well as disposable labo-ratory products such as culture tubes, pipettes, chromatography vials and other specialty laboratory glassware.

Plastics & Devices

Primary Packaging Glass

Life Science Research

Our Divisions

… are important

and convenient

solutions for everyday life.

Our Products

solutions for everyday life.

The Gerresheimer Group: more than 40 plants and approximately 11,000 employees worldwide.

Gerresheimer has developed longstanding

relationships with customers of all sizes around

the world. Our customer base includes

both international and national pharmaceutical

companies, american pharmacies as well

as companies in the diagnostic and medical

technology industries. We also supply numerous

cosmetic customers with our products.

Our Customers

Our Locations

ASIALATIN-AMERICA

USA EUROPE

Revenues by economic area

Revenues by market segment

Consolidated revenues 2015: EUR 1,377 Mio.

Employees by region

Gerresheimer in figures

2015

Europe 17 %

Germany 32 %

Americas 13 %

Emerging Markets 38 %(IMS-Definition)

(excl. Argentina, Brazil, Colombia, Mexico and Venezuela)

(excl. Germany, Poland, Romania, Russia, Turkey and Ukraine)

2015

Europe 34 %(excl. Germany, Poland, Romania, Russia, Turkey and Ukraine)

(excl. Argentina, Brazil, Colombia, Mexico and Venezuela)

(IMS-Definition)

Other 3 %

Emerging Markets 16 %

Americas 23 %

Germany 24 %

Pharma and Healthcare 83 %

Cosmetic 11 %

Other 6 %

2015

Change

in %

6.8

9.7

–

15.5

–

49.0

54.6

20.2

46.1

15.5

–

-8.3

–

-0.6

> 100

–

28.7

> -100

-0.2

> -100

2015

1,377.2

277.9

20.2

191.6

13.9

193.6

112.7

117.7

2,419.9

698.1

28.8

213.7

15.5

125.8

877.5

2.9

203.8

-600.1

-125.8

-396.3

2014

1.290.0

253.4

19.6

165.9

12.9

129.9

72.9

97.9

1,655.9

604.4

36.5

233.1

18.1

126.6

423.8

1.7

158.3

-125.0

-125.6

33.3

Group Key Figures

Financial Year end November 30

Results of Operations during Reporting Period in EUR m

Revenues

Adjusted EBITDA1)

in % of revenues

Adjusted EBITA2)

in % of revenues

Result from operations

Net income

Adjusted Net Income3)

Net Assets at Reporting Date in EUR m

Total assets

Equity

Equity ratio in %

Net working capital

in % of revenues of the last twelve months

Capital expenditure

Net financial debt

Adjusted EBITDA leverage4)

Financial and Liquidity Position during Reporting Period in EUR m

Cash flow from operating activities

Cash flow from investing activities

thereof cash paid for capital expenditure

Free cash flow before financing activities

1) Adjusted EBITDA: Earnings before income taxes, net finance expense, amortization

of fair value adjustments, depreciation and amortization, impairment losses, restructuring

expenses and one-off income and expenses. 2) Adjusted EBITA: Earnings before income taxes, net finance expense, amortization of

fair value adjustments, amortization, impairment losses, restructuring expenses and one-off

income and expenses. 3) Adjusted net income: Consolidated net income before non-cash amortization of fair value

adjustments, restructuring expenses, impairment losses, one-off income and expenses

(including significant non-cash expenses) and the related tax effects. 4) Adjusted EBITDA leverage: The relation of net financial debt to adjusted EBITDA of the

preceding twelve months.

IPO

Transparency standard

MDAX® membership since

WKN

ISIN

Listings

Number of shares at reporting date in million

Share price1) at reporting date in EUR

Market capitalization at reporting date in EUR m

Share price high1) during reporting period in EUR

Share price low1) during reporting period in EUR

Earnings per share in EUR

Adjusted earnings per share2) in EUR

Dividend per share in EUR

June 11, 2007

Prime Standard

December 2008

A0LD6E

DE000A0LD6E6

Berlin, Duesseldorf, Frankfurt (Xetra & floor trading), Hamburg, Hanover, Munich, Stuttgart

Gerresheimer Shares

Basic data for the shares

Shareholder structure by region

as of November 30, 2015

Key data for the shares

as of November 30, 2015

1) Xetra closing price.2) Adjusted net income after non-controlling interests divided by 31.4 m shares.3) Proposed appropriation of net earnings.

2015

31.4

73.90

2,320.5

76.32

41.99

3.32

3.41

0.853)

2014

31.4

44.44

1,395.4

56.42

42.31

2.11

2.89

0.753)

United Kingdom 33 %

Germany 8 %

North America 34 %

Other 9 %

Netherlands 16 %

2015

Vision – Mission – Values

Our Vision

Gerresheimer will become the leading global partner for enabling solutions that improve health and well-being.

Our success is driven by the passion of our people.

Our Mission

We will achieve our vision by:

understanding our customers and providing them with solutions to both their present and future needs

living our commitment to excellent quality and continuous innovation

leveraging our competence and technological leadership by acting as one global team

becoming a preferred employer with highly motivated and passionate employees all over the world and, in so doing, by

expanding our global reach and creating profitable and sustainable growth

Our Values

Integrity

Excellence

Innovation

Responsibility

Teamwork

Corporate responsibility is firmly anchored in our vision, mission and our values. We act in accordance with these principles at all our worldwide sites, and we take a holistic approach to sustainability. In addition to social and economic sustainability, we are particularly committed to the protection of the environment.

At Gerresheimer, environmental protection goes hand in hand with the efficient use of energy. We optimize energy usage by regularly overhauling and renewing our energy-intensive equipment such as the furnaces at our molded glass facilities.

The goals, strategies and success of our environmental initiatives and actions are regularly published as a result of our participation in the Carbon Disclosure Project (CDP). The goal of our environ-ment strategy is to decrease the emissions to revenue ratio.

www.gerresheimer.com/en/company/ corporate-responsibility.html

Corporate Responsibility

Clear improvement in CO2 emissions

relative to revenues (t/EUR k)

0.750

0.700

0.650

0.600

0.550

0.500

0.450

0.717 0.717 0.716 0.708

0.677

0.645

0.521

2008 2009 2010 2011 2012 2013 2014

Working at Gerresheimer

24/7 productionOur production lines never stand still. They are in operation 24 hours a day, 7 days a week. Yet we never lose focus of our responsibility as manufacturer of packaging for special pharmaceutical products.

International work environmentWe offer a professional and challenging work environment in a con-tinuously growing market at more than 40 sites in Europe, North and South America and Asia. Tradition, experience and continuityWe are a company with a long tradition and therefore outstanding competence and extensive experience. Long-serving employees are a reflection of our workforce’s loyalty to our organization. Health and well-beingAs an internationally leading partner to the pharma and healthcare industries we want to make a contribution to improving health and well-being. Opportunities and supportWe make targeted investments in our employees with the aim of offering the right career opportunities to people who know what they want and have the passion and determination to achieve it.

www.gerresheimer.com/jobs-careers

Gerresheimer AGKlaus-Bungert-Strasse 4 · 40468 Duesseldorf · GermanyPhone +49 211 6181-00Fax +49 211 6181-295E-mail info@gerresheimer.com

Group Communication & MarketingPhone +49 211 6181-250Fax +49 211 6181-241E-mail j.kuerten@gerresheimer.com

Investor RelationsPhone +49 211 6181-257Fax +49 211 6181-121E-mail gerresheimer.ir@gerresheimer.com

www.gerresheimer.com

Contact

www.facebook.com/Gerresheimer.International

https://plus.google.com/+gerresheimer/posts

www.linkedin.com/company/gerresheimer

www.youtube.com/user/Gerresheimer